SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-182697
Filing Date
2019-06-26
Accepted
2019-06-26 17:03:36
Documents
5
Period of Report
2019-08-08
Effectiveness Date
2019-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d766488ddef14a.htm DEF 14A 1283186
2 GRAPHIC g766488g44i94.jpg GRAPHIC 24794
3 GRAPHIC g766488g65t06.jpg GRAPHIC 27367
4 GRAPHIC g766488pc1.jpg GRAPHIC 170826
5 GRAPHIC g766488pc2.jpg GRAPHIC 273102
  Complete submission text file 0001193125-19-182697.txt   1968204
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 19922290
SIC: 2834 Pharmaceutical Preparations